ChromoGenics appoints new CFO

Report this content

Erik Elfström is appointed new CFO for ChromoGenics as of September 1, 2022.

ChromoGenics has completed the recruitment of a permanent CFO, after number of years of filling the CFO role on a consultancy basis. Erik Elfström is appointed CFO & Head of Investor Relations as of September 1, 2022. Erik has a Bachelors Degree in Finance with a specialty in accounting from Högskolan in Gävle and has most recently been the CFO of Hectronic AB.

”This appointment is in line with the strengthening of our our management team that has been done.. Erik is a very competent and engaged CFO with broad experience from high-tech growth companies. We are very please to have been able to attract him to ChromoGenics.”

Göran Atterling is the acting CFO until Erik starts in September and will be available during a transition period.

Contact:
Fredrik Fränding, CEO
Tel: +46 (0)18 430 0430
Göran Atterling, CFO & Head of Communications
Tel: +46 (0)18 430 0430
Email:
info@chromogenics.com   

ChromoGenics

About ChromoGenics
ChromoGenics is a proptech company that produces dynamic glass for real estate. The company’s product ConverLight® Dynamic, controls indoor comfort with high daylight transmission, great view and solar heat blocking and thereby reduces cost of cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are laminated in plastic film and then laminated between glass. The plastic film is easy to transport, so long shipments of bulky glass can be avoided. ChromoGenics also offers static glass, ConverLight® Static, and the ConverLight® Energy facade glass solution. ChromoGenics’ stock was listed on Nasdaq First North Growth Market in 2017 and has supplied glass technology to several major real estate companies.

ChromoGenics originates from world-leading research at Ångströmlaboratoriet at Uppsala University. The company’s production facility in Uppsala has been partially financed with conditional loans from Energimyndigheten (Energy Authority) in Sweden. ChromoGenics’ share (CHRO) is listed on Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser: certifiedadviser@penser.se